Clinical Equivalence of Azelastine Hydrochloride and Fluticasone Propionate, 137/50 mcg Nasal Spray to Dymista™

Clinical trial NCT02249663 · UNKNOWN

Trial details

NCT number: NCT02249663
Sponsor: Teva Pharmaceuticals USA
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Seasonal Allergic Rhinitis

Start date: 2014-08-01
Primary completion: 2015-02-01
Enrollment: 1535

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.